Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmacology, Biochemistry, and Behavior|February 16, 2025
Striatal dopamine D2, adenosine A2A and cannabinoid CB1 receptors balance as a target against non-cognitive symptoms in a mouse model of Alzheimer's diseaseLaura Gómez-Acero, Nuria Sánchez-Fernández, Paula Subirana, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 18, 2025
Long-lasting behavioral, molecular and functional connectivity alterations after chronic THC exposure during adolescence in miceLaura Gómez-Acero, Federico Varriano, Nuria Sánchez-Fernández, et al.
Acta Neuropsychiatrica|August 22, 2023
Cannabidiol negatively modulates adenosine A2A receptor functioning in living cellsNuria Sánchez-Fernández, Laura Gómez-Acero, Laura I Sarasola, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 3, 2023
Unique effect of clozapine on adenosine A2A-dopamine D2 receptor heteromerizationMarta Valle-León, Nil Casajuana-Martin, Claudia Llinas Del Torrent, et al.
British Journal of Pharmacology|June 22, 2026
Cannabinoid and adenosine A2A receptor crosstalk regulates postnatal and adult hippocampal neurogenesisRui S Rodrigues, Adam Armada-Moreira, Laura Gómez-Acero, et al.
Alzheimer'S Research & Therapy|September 21, 2022
Nanoscale alterations in GABAB receptors and GIRK channel organization on the hippocampus of APP/PS1 miceAlejandro Martín-Belmonte, Carolina Aguado, Rocío Alfaro-Ruiz, et al.
Molecular Neurobiology|December 12, 2019
β-Catenin Role in the Vulnerability/Resilience to Stress-Related Disorders Is Associated to Changes in the Serotonergic SystemEmilio Garro-Martínez, Rebeca Vidal, Albert Adell, et al.
NPJ Parkinson'S Disease|September 10, 2024
GPR37 processing in neurodegeneration: a potential marker for Parkinson's Disease progression rateJosep Argerich, Leonardo D Garma, Marc López-Cano, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 5, 2024
A combination of Δ9-tetrahydrocannabinol and cannabidiol modulates glutamate dynamics in the hippocampus of an animal model of Alzheimer's diseaseNuria Sánchez-Fernández, Laura Gómez-Acero, Anna Castañé, et al.
Pageof 1